Cel Sci CVM
NYSE CVM
$2.26 +0.18 (+8.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cel Sci (CVM) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Cel Sci's Return on Capital Employed [ROCE] was -154.21% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 6.88 percentage points from -161.08% a year earlier but down 10.81 percentage points from the prior quarter.

Analysis

Cel Sci (CVM) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Return on Capital Employed [ROCE] at Cel Sci came in at -110.54%, down 1.40 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for three consecutive fiscal years, with a five-year change of -13.33 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Capital Employed [ROCE] was -109.15% in FY2024 (-19.06 pp), -90.09% in FY2023 (-28.47 pp), -61.61% in FY2022 (+5.09 pp) and -66.70% in FY2021 (+30.52 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -161.08% (fiscal Q3 2025) and -49.03% (fiscal Q4 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in two of the last eight quarters, with an average year-over-year change of -6.00 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q1 2022 (a gain of 29.48 percentage points); the worst was fiscal Q4 2023 (a drop of 48.29 percentage points).
  • Per Business Quant data, CVM's Return on Capital Employed [ROCE] in the three fiscal quarters before Q3 2026 was -143.40% (Q2 2026), -113.67% (Q1 2026) and -129.79% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Cel Sci 4.09 Mn -21.56 Mn - -154.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -154.21%
Mar 31, 2026 -143.40%
Dec 31, 2025 -113.67%
Sep 30, 2025 -129.79%
Jun 30, 2025 -161.08%
Mar 31, 2025 -142.87%
Dec 31, 2024 -128.25%
Sep 30, 2024 -126.00%
Jun 30, 2024 -128.53%
Mar 31, 2024 -120.25%
Dec 31, 2023 -122.46%
Sep 30, 2023 -121.82%
Jun 30, 2023 -109.99%
Mar 31, 2023 -92.87%
Dec 31, 2022 -81.47%
Sep 30, 2022 -73.53%
Jun 30, 2022 -62.98%
Mar 31, 2022 -59.78%
Dec 31, 2021 -52.29%
Sep 30, 2021 -49.03%
API Access

Cel Sci Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CVM&period=max&api_key=YOUR_API_KEY